Published :
Tables : 49
Figures : 44
Category : Healthcare
No. of Pages : 226
Report Code : HC-U3286
Downstream Bioprocessing Controllers Market is estimated to value over CAGR of over 17% during the forecast period 2022 to 2028. Rising insistence for biopharmaceuticals, increased acceptance of single-use technology, expansion of the capacity by the companies manufacturing biopharmaceutical products are some of the key factors driving the market growth. Furthermore, rising penetration of large molecules and biologics shall increase the acceptance of downstream methods, thereby proliferating the market. Purity, reasonable unit cost and efficacy are some of the key parameters to be considered for producing drugs. Downstream technique is often used in both industrial as well as lab applications due to an escalated insistence for biologics, which shall augment the downstream bioprocessing controllers market growth. High throughput in the development process, perfusion chromatography, usage of data analytics and affinity chromatography are some of the crucial developments in downstream processing. Furthermore, the advantages related to the single use technology like substantial reduction in the facility construction time and capital cost which shall accelerate the growth of the market. Other benefits like improves mobility, increased scalability, eliminating cross contamination risk, reduced demand for sterilization and cleaning and high productivity shall boost the demand for downstream method significantly. The key market players are initiating multiple research and development activities for cutting down the total production cost, thereby minimizing the cost of retail products. These activities have escalated the investments in biotech research, thereby shortening the time of processing and the scope of throughput. Major key players involved in Downstream Bioprocessing Controllers Market: • Merck Group • Danaher Corporation • GE Healthcare • ARTeSYN Biosolutions Ireland Ltd • Sepragen Corporation • Parker-Hannifin Corporation • 3M Company • VERDOT Ips² • Repligen Corporation • Sartorius (Note: The list of the major players will be updated with the latest market scenario and trends) Market Segmentation: By Procedure • Chromatography • Tangential Flow Filtration By Product • Chromatography Controller System • TFF Controller System • Disposable Floe Path By Application • Commercial Bioprocessing o Monoclonal Antibody Production o Therapeutic Protein Production o Vaccine Production o Cell and Gene Therapy • Research Bioprocessing By End User • Pharmaceutical and Biotechnology Companies • Academic and Research Institutes • Contract Research Organizations • Food and Beverage Companies By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is classified into procedure, product, application, end user and region. The procedure segment is fragmented into chromatography and tangential flow filtration. The tangential flow filtration procedure is predicted to hold the largest downstream bioprocessing controllers market share owing to a rise in the acceptance of tangential flow filtration processes for removing biofilm, bioburden and reducing endotoxin from biopharmaceutical fluids and all this with no effect on the product quality. Product-wise, the market is divided into chromatography controller system, TFF controller system, disposable flow path. The TFF products like disposable flow path dominated the market and this can be credited to an increased acceptance of TFF processes implemented with single use technology in meeting the rising insistence for concentrated protein with reduced time and capital investment. The application segment is divided into commercial bioprocessing and research bioprocessing. The commercial bioprocessing segment is fragmented into monoclonal antibody production, therapeutic protein production, vaccine production and cell and gene therapy. The commercial bioprocessing is predicted to lead the market and this mainly due to increased insistence for biopharmaceutical products, rise in the number of approvals for antibody products. The end user segment is categorised into pharmaceutical and biotechnology companies, contract manufacturing organization and academic and research institutes. The pharmaceutical and biotechnology companies led the market, and this can be credited to a high rate of consumption of bioprocessing consumables and equipment by these companies. Regional Analysis: The North America region is anticipated to dominate the market owing to the advancements in downstream technology and a strong presence of key biopharmaceutical companies in the region. Furthermore, the government has heavily invested in the research and development activities pertaining to bioprocessing controllers which has boosted the market growth in the region. The Asia Pacific region is expected to grow at a substantial rate during the forecast period with key players expanding their businesses in the region. For instance, JHL Biotech of Taiwan uses modular SUT that is provided by GE Healthcare Life Sciences for constructing a biopharma facility in the province of Wuhan, China. There has been a rise in the number of approvals of biologics in developing and developed countries like China, Japan. For example, Chugai Pharmaceutical Co. Ltd. from Japan and the National Cancer Center, Japan has signed a research agreement for the project Master Key which shall promote R&D in genomic medicines and cancer medicines. Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global downstream bioprocessing controllers market by procedure, by product, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Rising insistence for biopharmaceuticals, increased acceptance of single-use technology, expansion of the capacity by the companies manufacturing biopharmaceutical products are some of the key factors driving the market growth. Furthermore, rising penetration of large molecules and biologics shall increase the acceptance of downstream methods, thereby proliferating the market. Purity, reasonable unit cost and efficacy are some of the key parameters to be considered for producing drugs. Downstream technique is often used in both industrial as well as lab applications due to an escalated insistence for biologics, which shall augment the downstream bioprocessing controllers market growth. High throughput in the development process, perfusion chromatography, usage of data analytics and affinity chromatography are some of the crucial developments in downstream processing. Furthermore, the advantages related to the single use technology like substantial reduction in the facility construction time and capital cost which shall accelerate the growth of the market. Other benefits like improves mobility, increased scalability, eliminating cross contamination risk, reduced demand for sterilization and cleaning and high productivity shall boost the demand for downstream method significantly. The key market players are initiating multiple research and development activities for cutting down the total production cost, thereby minimizing the cost of retail products. These activities have escalated the investments in biotech research, thereby shortening the time of processing and the scope of throughput.
Major key players involved in Downstream Bioprocessing Controllers Market: • Merck Group • Danaher Corporation • GE Healthcare • ARTeSYN Biosolutions Ireland Ltd • Sepragen Corporation • Parker-Hannifin Corporation • 3M Company • VERDOT Ips² • Repligen Corporation • Sartorius
(Note: The list of the major players will be updated with the latest market scenario and trends)
Market Segmentation:
By Procedure • Chromatography • Tangential Flow Filtration
By Product • Chromatography Controller System • TFF Controller System • Disposable Floe Path
By Application • Commercial Bioprocessing o Monoclonal Antibody Production o Therapeutic Protein Production o Vaccine Production o Cell and Gene Therapy • Research Bioprocessing
By End User • Pharmaceutical and Biotechnology Companies • Academic and Research Institutes • Contract Research Organizations • Food and Beverage Companies
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is classified into procedure, product, application, end user and region. The procedure segment is fragmented into chromatography and tangential flow filtration. The tangential flow filtration procedure is predicted to hold the largest downstream bioprocessing controllers market share owing to a rise in the acceptance of tangential flow filtration processes for removing biofilm, bioburden and reducing endotoxin from biopharmaceutical fluids and all this with no effect on the product quality. Product-wise, the market is divided into chromatography controller system, TFF controller system, disposable flow path. The TFF products like disposable flow path dominated the market and this can be credited to an increased acceptance of TFF processes implemented with single use technology in meeting the rising insistence for concentrated protein with reduced time and capital investment. The application segment is divided into commercial bioprocessing and research bioprocessing. The commercial bioprocessing segment is fragmented into monoclonal antibody production, therapeutic protein production, vaccine production and cell and gene therapy. The commercial bioprocessing is predicted to lead the market and this mainly due to increased insistence for biopharmaceutical products, rise in the number of approvals for antibody products. The end user segment is categorised into pharmaceutical and biotechnology companies, contract manufacturing organization and academic and research institutes. The pharmaceutical and biotechnology companies led the market, and this can be credited to a high rate of consumption of bioprocessing consumables and equipment by these companies.
Regional Analysis:
The North America region is anticipated to dominate the market owing to the advancements in downstream technology and a strong presence of key biopharmaceutical companies in the region. Furthermore, the government has heavily invested in the research and development activities pertaining to bioprocessing controllers which has boosted the market growth in the region. The Asia Pacific region is expected to grow at a substantial rate during the forecast period with key players expanding their businesses in the region. For instance, JHL Biotech of Taiwan uses modular SUT that is provided by GE Healthcare Life Sciences for constructing a biopharma facility in the province of Wuhan, China. There has been a rise in the number of approvals of biologics in developing and developed countries like China, Japan. For example, Chugai Pharmaceutical Co. Ltd. from Japan and the National Cancer Center, Japan has signed a research agreement for the project Master Key which shall promote R&D in genomic medicines and cancer medicines.
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global downstream bioprocessing controllers market by procedure, by product, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Downstream Bioprocessing Controllers Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Downstream Bioprocessing Controllers Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Downstream Bioprocessing Controllers Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Downstream Bioprocessing Controllers Market, By Procedure Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 7.1 Chromatography 7.2 Tangential Flow Filtration 8. Downstream Bioprocessing Controllers Market, By Product Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 8.1 Chromatography Controller System 8.2 TFF Controller System 8.3 Disposable Floe Path 9. Downstream Bioprocessing Controllers Market, By Application Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 9.1 Commercial Bioprocessing 9.1.1 Monoclonal Antibody Production 9.1.2 Therapeutic Protein Production 9.1.3 Vaccine Production 9.1.4 Cell and Gene Therapy 9.2 Research Bioprocessing 10. Downstream Bioprocessing Controllers Market, By End User Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 10.1 Pharmaceutical and Biotechnology Companies 10.2 Academic and Research Institutes 10.3 Contract Research Organizations 10.4 Food and Beverage Companies 11. North America Downstream Bioprocessing Controllers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Downstream Bioprocessing Controllers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Downstream Bioprocessing Controllers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Downstream Bioprocessing Controllers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1 Merck Group 17.1.1. Company Overview (HQ, Business Segments, Employee Strength) 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2 GE Healthcare 17.2.1. Company Overview (HQ, Business Segments, Employee Strength) 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3 ARTeSYN Biosolutions Ireland Ltd 17.3.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4 Sepragen Corporation 17.4.1. Company Overview (HQ, Business Segments, Employee Strength) 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5 Parker-Hannifin Corporation 17.5.1. Company Overview (HQ, Business Segments, Employee Strength) 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6 3M Company 17.6.1. Company Overview (HQ, Business Segments, Employee Strength) 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7 VERDOT Ips² 17.7.1. Company Overview (HQ, Business Segments, Employee Strength) 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8 Repligen Corporation 17.8.1. Company Overview (HQ, Business Segments, Employee Strength) 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9 Sartorius AG 17.9.1. Company Overview (HQ, Business Segments, Employee Strength) 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Downstream Bioprocessing Controllers Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Downstream Bioprocessing Controllers Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Downstream Bioprocessing Controllers Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Downstream Bioprocessing Controllers Market, By Procedure Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 7.1 Chromatography 7.2 Tangential Flow Filtration
8. Downstream Bioprocessing Controllers Market, By Product Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 8.1 Chromatography Controller System 8.2 TFF Controller System 8.3 Disposable Floe Path
9. Downstream Bioprocessing Controllers Market, By Application Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 9.1 Commercial Bioprocessing 9.1.1 Monoclonal Antibody Production 9.1.2 Therapeutic Protein Production 9.1.3 Vaccine Production 9.1.4 Cell and Gene Therapy 9.2 Research Bioprocessing
10. Downstream Bioprocessing Controllers Market, By End User Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 10.1 Pharmaceutical and Biotechnology Companies 10.2 Academic and Research Institutes 10.3 Contract Research Organizations 10.4 Food and Beverage Companies
11. North America Downstream Bioprocessing Controllers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Downstream Bioprocessing Controllers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Downstream Bioprocessing Controllers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Downstream Bioprocessing Controllers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1 Merck Group 17.1.1. Company Overview (HQ, Business Segments, Employee Strength) 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2 GE Healthcare 17.2.1. Company Overview (HQ, Business Segments, Employee Strength) 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3 ARTeSYN Biosolutions Ireland Ltd 17.3.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4 Sepragen Corporation 17.4.1. Company Overview (HQ, Business Segments, Employee Strength) 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5 Parker-Hannifin Corporation 17.5.1. Company Overview (HQ, Business Segments, Employee Strength) 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6 3M Company 17.6.1. Company Overview (HQ, Business Segments, Employee Strength) 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7 VERDOT Ips² 17.7.1. Company Overview (HQ, Business Segments, Employee Strength) 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8 Repligen Corporation 17.8.1. Company Overview (HQ, Business Segments, Employee Strength) 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9 Sartorius AG 17.9.1. Company Overview (HQ, Business Segments, Employee Strength) 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics